Logo image of SREA

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Stock Fundamental Analysis

NYSE:SREA - New York Stock Exchange, Inc. - US8168516040 - Currency: USD

22.58  -0.12 (-0.53%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SREA. SREA was compared to 25 industry peers in the Multi-Utilities industry. There are concerns on the financial health of SREA while its profitability can be described as average. SREA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SREA had positive earnings in the past year.
In the past year SREA had a positive cash flow from operations.
Each year in the past 5 years SREA has been profitable.
In the past 5 years SREA always reported a positive cash flow from operatings.
SREA Yearly Net Income VS EBIT VS OCF VS FCFSREA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

With an excellent Return On Assets value of 2.93%, SREA belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
SREA has a Return On Equity (9.02%) which is in line with its industry peers.
SREA's Return On Invested Capital of 2.86% is on the low side compared to the rest of the industry. SREA is outperformed by 92.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SREA is in line with the industry average of 3.76%.
Industry RankSector Rank
ROA 2.93%
ROE 9.02%
ROIC 2.86%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SREA Yearly ROA, ROE, ROICSREA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 21.37%, SREA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
SREA's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 22.46%, SREA is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
SREA's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 22.46%
PM (TTM) 21.37%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SREA Yearly Profit, Operating, Gross MarginsSREA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SREA is destroying value.
The number of shares outstanding for SREA has been increased compared to 1 year ago.
The number of shares outstanding for SREA has been increased compared to 5 years ago.
SREA has a worse debt/assets ratio than last year.
SREA Yearly Shares OutstandingSREA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SREA Yearly Total Debt VS Total AssetsSREA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

SREA has an Altman-Z score of 0.56. This is a bad value and indicates that SREA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.56, SREA is doing worse than 76.00% of the companies in the same industry.
SREA has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SREA (1.07) is better than 96.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC0.58
WACC4.94%
SREA Yearly LT Debt VS Equity VS FCFSREA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 0.55 indicates that SREA may have some problems paying its short term obligations.
SREA's Current ratio of 0.55 is on the low side compared to the rest of the industry. SREA is outperformed by 84.00% of its industry peers.
SREA has a Quick Ratio of 0.55. This is a bad value and indicates that SREA is not financially healthy enough and could expect problems in meeting its short term obligations.
SREA has a Quick ratio (0.49) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.49
SREA Yearly Current Assets VS Current LiabilitesSREA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.22% over the past year.
Measured over the past years, SREA shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.31% on average per year.
SREA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.14%.
The Revenue has been growing slightly by 4.04% on average over the past years.
EPS 1Y (TTM)0.22%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%32.74%
Revenue 1Y (TTM)-21.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%7.65%

3.2 Future

Based on estimates for the next years, SREA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.95% on average per year.
SREA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.61% yearly.
EPS Next Y12.59%
EPS Next 2Y10.25%
EPS Next 3Y9.41%
EPS Next 5Y9.95%
Revenue Next Year4.34%
Revenue Next 2Y4.25%
Revenue Next 3Y3.97%
Revenue Next 5Y3.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SREA Yearly Revenue VS EstimatesSREA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SREA Yearly EPS VS EstimatesSREA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

SREA is valuated cheaply with a Price/Earnings ratio of 4.89.
Based on the Price/Earnings ratio, SREA is valued cheaply inside the industry as 88.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 29.71, SREA is valued rather cheaply.
SREA is valuated cheaply with a Price/Forward Earnings ratio of 4.34.
Based on the Price/Forward Earnings ratio, SREA is valued cheaply inside the industry as 88.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.34. SREA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.89
Fwd PE 4.34
SREA Price Earnings VS Forward Price EarningsSREA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SREA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SREA is cheaper than 72.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.64
SREA Per share dataSREA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

SREA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y10.25%
EPS Next 3Y9.41%

More info and screens

4

5. Dividend

5.1 Amount

SREA has a Yearly Dividend Yield of 3.65%.
SREA's Dividend Yield is a higher than the industry average which is at 3.79.
SREA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 3.65%

5.2 History

The dividend of SREA decreases each year by -9.71%.
SREA has been paying a dividend for over 5 years, so it has already some track record.
SREA has decreased its dividend recently.
Dividend Growth(5Y)-9.71%
Div Incr Years0
Div Non Decr Years1
SREA Yearly Dividends per shareSREA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

54.77% of the earnings are spent on dividend by SREA. This is a bit on the high side, but may be sustainable.
DP54.77%
EPS Next 2Y10.25%
EPS Next 3Y9.41%
SREA Yearly Income VS Free CF VS DividendSREA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SREA Dividend Payout.SREA Dividend Payout, showing the Payout Ratio.SREA Dividend Payout.PayoutRetained Earnings

More info and screens

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (3/6/2025, 4:10:02 PM)

22.58

-0.12 (-0.53%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners93.92%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap14.30B
Analysts79.13
Price Target27.35 (21.12%)
Short Float %0%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 3.65%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP54.77%
Div Incr Years0
Div Non Decr Years1
Ex-Date03-14 2025-03-14 (0.359375)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.73%
Min EPS beat(2)-16.27%
Max EPS beat(2)-7.18%
EPS beat(4)0
Avg EPS beat(4)-7.52%
Min EPS beat(4)-16.27%
Max EPS beat(4)-0.63%
EPS beat(8)4
Avg EPS beat(8)-1.67%
EPS beat(12)8
Avg EPS beat(12)2.1%
EPS beat(16)11
Avg EPS beat(16)2.53%
Revenue beat(2)0
Avg Revenue beat(2)-18.51%
Min Revenue beat(2)-22.35%
Max Revenue beat(2)-14.67%
Revenue beat(4)0
Avg Revenue beat(4)-21.2%
Min Revenue beat(4)-35.37%
Max Revenue beat(4)-12.42%
Revenue beat(8)1
Avg Revenue beat(8)-6.76%
Revenue beat(12)4
Avg Revenue beat(12)-2.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.59%
PT rev (1m)0%
PT rev (3m)5.53%
EPS NQ rev (1m)-9.58%
EPS NQ rev (3m)-12.83%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)-2%
Revenue NQ rev (3m)-5.28%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)2.58%
Valuation
Industry RankSector Rank
PE 4.89
Fwd PE 4.34
P/S 1.08
P/FCF N/A
P/OCF 2.91
P/B 0.46
P/tB 0.49
EV/EBITDA 8.64
EPS(TTM)4.62
EY20.46%
EPS(NY)5.2
Fwd EY23.04%
FCF(TTM)-6.63
FCFYN/A
OCF(TTM)7.75
OCFY34.31%
SpS20.82
BVpS49.32
TBVpS46.33
PEG (NY)0.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.93%
ROE 9.02%
ROCE 3.43%
ROIC 2.86%
ROICexc 2.91%
ROICexgc 2.98%
OM 22.46%
PM (TTM) 21.37%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexcg growth 3Y-8.37%
ROICexcg growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Debt/EBITDA 6.22
Cap/Depr 373.57%
Cap/Sales 69.05%
Interest Coverage 2.46
Cash Conversion 90.89%
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.49
Altman-Z 0.56
F-Score5
WACC4.94%
ROIC/WACC0.58
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.22%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%32.74%
EPS Next Y12.59%
EPS Next 2Y10.25%
EPS Next 3Y9.41%
EPS Next 5Y9.95%
Revenue 1Y (TTM)-21.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%7.65%
Revenue Next Year4.34%
Revenue Next 2Y4.25%
Revenue Next 3Y3.97%
Revenue Next 5Y3.61%
EBIT growth 1Y-20.27%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year73.37%
EBIT Next 3Y25.44%
EBIT Next 5Y14.24%
FCF growth 1Y-50.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.08%
OCF growth 3Y8.5%
OCF growth 5Y9.71%